Discovery - University of Dundee - Online Publications

Library & Learning Centre

Oncogene

  1. The heparan sulfate sulfotransferase 3-OST3A (HS3ST3A) is a novel tumor regulator and a prognostic marker in breast cancer

    Mao, X., Gauche, C., Coughtrie, M. W. H., Bui, C., Gulberti, S., Merhi-Soussi, F., Ramalanjaona, N., Bertin-Jung, I., Diot, A., Dumas, D., De Freitas Caires, N., Thompson, A. M., Bourdon, J-C., Ouzzine, M. & Fournel-Gigleux, S. 4 Apr 2016 In : Oncogene. 13 p.

    Research output: Contribution to journalArticle

  2. The NEDD8 inhibitor MLN4924 increases the size of the nucleolus and activates p53 through the ribosomal-Mdm2 pathway

    Bailly, A., Perrin, A., Bou Malhab, L. J., Pion, E., Larance, M., Nagala, M., Smith, P., O'Donohue, M-F., Gleizes, P-E., Zomerdijk, J., Lamond, A. I. & Xirodimas, D. P. 28 Jan 2016 In : Oncogene. 35, 4, p. 415-426 12 p.

    Research output: Contribution to journalArticle

  3. PML isoforms IV and V contribute to adenovirus-mediated oncogenic transformation by functionally inhibiting the tumor-suppressor p53

    Wimmer, P., Berscheminski, J., Blanchette, P., Groitl, P., Branton, P. E., Hay, R. T., Dobner, T. & Schreiner, S. 7 Jan 2016 In : Oncogene. 35, p. 69-82 14 p.

    Research output: Contribution to journalArticle

  4. Prohibitin is required for transcriptional repression by the WT1-BASP1 complex

    Toska, E., Shandilya, J., Goodfellow, S. J., Medler, K. F. & Roberts, S. G. E. 23 Oct 2014 In : Oncogene. 33, 43, p. 5100-5108 9 p.

    Research output: Contribution to journalArticle

  5. The degradation of p53 and its major E3 ligase Mdm2 is differentially dependent on the proteasomal ubiquitin receptor S5a.

    Sparks, A., Dayal, S., Das, J., Robertson, P., Menendez, S. & Saville, M. K. Oct 2014 In : Oncogene. 33, 38, p. 4685-4696 12 p.

    Research output: Contribution to journalArticle

  6. PDK1 controls upstream PI3K expression and PIP3 generation

    Dieterle, A. M., Böhler, P., Keppeler, H., Alers, S., Berleth, N., Drießen, S., Hieke, N., Pietkiewicz, S., Löffler, A. S., Peter, C., Gray, A., Leslie, N. R., Shinohara, H., Kurosaki, T., Engelke, M., Wienands, J., Bonin, M., Wesselborg, S. & Stork, B. 5 Jun 2014 In : Oncogene. 33, 23, p. 3043-3053 11 p.

    Research output: Contribution to journalArticle

  7. HIF-independent role of prolyl hydroxylases in the cellular response to amino acids

    Durán, R. V., Mackenzie, E. D., Boulahbel, H., Frezza, C., Heiserich, L., Tardito, S., Bussolati, O., Rocha, S., Hall, M. N. & Gottlieb, E. 19 Sep 2013 In : Oncogene. 32, 38, p. 4549-4556 8 p.

    Research output: Contribution to journalArticle

  8. The RNA helicase p68 (DDX5) is selectively required for the induction of p53-dependent p21 expression and cell-cycle arrest after DNA damage

    Nicol, S. M., Bray, S. E., Derek Black, H., Lorimore, S. A., Wright, E. G., Lane, D. P., Meek, D. W., Coates, P. J. & Fuller-Pace, F. V. 18 Jul 2013 In : Oncogene. 32, 29, p. 3461-3469 9 p.

    Research output: Contribution to journalArticle

  9. The p53 isoform, Δ133p53α, stimulates angiogenesis and tumour progression

    Bernard, H., Garmy-Susini, B., Ainaoui, N., Van Den Berghe, L., Peurichard, A., Javerzat, S., Bikfalvi, A., Lane, D. P., Bourdon, J. C. & Prats, A-C. 25 Apr 2013 In : Oncogene. 32, 17, p. 2150-2160 11 p.

    Research output: Contribution to journalArticle

  10. p53 is activated in response to disruption of the pre-mRNA splicing machinery

    Allende-Vega, N., Dayal, S., Agarwala, U., Sparks, A., Bourdon, J-C. & Saville, M. K. 3 Jan 2013 In : Oncogene. 32, 1, p. 1-14 14 p.

    Research output: Contribution to journalArticle

Previous 1 2 3 4 5 6 7 8 Next

Library & Learning Centre

Contact | Accessibility | Policy